These emerging therapies , Tirzepatide , represent a groundbreaking advancement in addressing type 2 diabetes and possibly other ailments . They are categorized as GLP-1 hormone agonists , signifying Anti-Obesity Drug they to mimic the body's GLP-1 hormone , boosting metabolic production and suppressing appetite . Although Semaglutide every functio